Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 25, 2026 19:57 ET | Source: Palvella Therapeutics Inc.

Palvella Therapeutics Announces Pricing of Upsized Public Offering

WAYNE, Pa., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. (“Palvella”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commercializing novel...
February 25, 2026 18:50 ET | Source: Gaming and Leisure Properties, Inc.

Gaming and Leisure Properties Announces Pricing of $800,000,000 of 5.625% Senior Notes Due 2036

WYOMISSING, Pa., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Gaming and Leisure Properties, Inc. (“GLPI”) (NASDAQ: GLPI) today announced the pricing of a public offering of $800,000,000 aggregate principal...
February 25, 2026 16:05 ET | Source: Talkspace

Talkspace to Participate in Upcoming Investor Conferences

NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Talkspace (Nasdaq: TALK), a leading behavioral healthcare company, today announced that members of senior management will participate in the following...
February 24, 2026 20:50 ET | Source: Fairfax Financial Holdings Limited

Fairfax Launches C$650 Million Senior Notes Offering

Not for distribution to U.S. news wire services or dissemination in the United States. The base shelf prospectus is accessible, and the shelf prospectus supplement for this offering will be...
February 24, 2026 16:34 ET | Source: Phillips Edison & Company, Inc.

Phillips Edison & Company Announces Pricing of Offering of $350 Million Aggregate Principal Amount of 4.750% Senior Unsecured Notes Due 2033

CINCINNATI, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or the “Company”), one of the nation’s largest owners and operators of high-quality,...
February 24, 2026 16:05 ET | Source: Palvella Therapeutics Inc.

Palvella Therapeutics Announces Proposed Public Offering

WAYNE, Pa., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. (“Palvella”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commercializing novel...
February 18, 2026 16:38 ET | Source: Regency Centers Corporation

Regency Centers Prices $450 Million Senior Unsecured Notes Offering

JACKSONVILLE, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Regency Centers Corporation (“Regency,” “Regency Centers,” or the “Company”) (Nasdaq: REG) announced today that its operating partnership,...
February 17, 2026 16:00 ET | Source: HealthEquity, Inc.

HealthEquity Delivers Record Q4 and Standout Fiscal 2026 Sales Metrics

DRAPER, Utah, Feb. 17, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation's largest health savings account (“HSA”) custodian by number of...
February 17, 2026 08:00 ET | Source: ARKO CORP.

ARKO Corp. and ARKO Petroleum Corp. Announce Closing of ARKO Petroleum Corp.’s Initial Public Offering

RICHMOND, Va., Feb. 17, 2026 (GLOBE NEWSWIRE) -- ARKO Corp. (Nasdaq: ARKO) (“ARKO”) and ARKO Petroleum Corp. (Nasdaq: APC) (“APC”), today announced the closing on February 13, 2026 of APC’s initial...
February 12, 2026 16:05 ET | Source: Roadzen Inc.

Roadzen Reports Strongest Quarter in Two Years with $14.4 Million Third Quarter Revenue and Sixth Consecutive Quarter of Adjusted EBITDA Improvement

Roadzen delivers 18.8% revenue increase and reduces operating loss by 25.4% over prior-year quarter Strategic wins, new contracts and acquisitions, expand Roadzen’s U.S. market presence and...